JAMA's editor stresses authors' need to disclose  financial ties

doi:10.1136/bmj.333.7564.370-c

BMJ 2006;333:370 (19 August), doi:10.1136/bmj.333.7564.370-c

News extra

JAMA’s editor stresses authors’ need to disclose financial ties

New York Janice Tanne

The editor of JAMA, the Journal of the American Medical Association, has said that the journal would continue its efforts, begun in 1985, to make readers aware of the financial ties of authors.

In an editorial published online ahead of print on 8 August, JAMA's editor, Catherine DeAngelis, states, “Peer-reviewed medical journals must always place the interests of patients above all else” (www.jama-assn.org, doi:10.1001/jama.296.8.jed60051).

“I think it’s very important now. At least in the United States, the vast majority of clinical research is paid for by drug companies. There’s nothing wrong with that. Somebody’s got to pay for research,” Dr DeAngelis told the BMJ. But when authors fail to disclose ties with drug companies, readers may perceive that authors have something to hide, she added. “In my editorial I went way out of my way to say that even in . . . [Full text of this article]

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?